Khadija El Hadri
Paris, 75005, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
A new model and precious tool to study molecular mechanisms of macrophage aging.
Journal: Aging
Published: January 31, 2024
Inflammation, Oxidative Stress, Senescence in Atherosclerosis: Thioredoxine-1 as an Emerging Therapeutic Target.
Journal: International journal of molecular sciences
Published: November 30, 2021
A thioredoxin-mimetic peptide exerts potent anti-inflammatory, antioxidant, and atheroprotective effects in ApoE2.Ki mice fed high fat diet.
Journal: Cardiovascular research
Published: October 02, 2017
Inhibition of the Inflammasome NLRP3 by Arglabin Attenuates Inflammation, Protects Pancreatic β-Cells from Apoptosis, and Prevents Type 2 Diabetes Mellitus Development in ApoE2Ki Mice on a Chronic High-Fat Diet.
Journal: The Journal of pharmacology and experimental therapeutics
Published: February 17, 2016
Anti-inflammatory and antiatherogenic effects of the NLRP3 inflammasome inhibitor arglabin in ApoE2.Ki mice fed a high-fat diet.
Journal: Circulation
Published: January 24, 2015
The thioredoxin system as a therapeutic target in human health and disease.
Journal: Antioxidants & redox signaling
Published: December 19, 2012
Truncated thioredoxin (Trx-80) promotes pro-inflammatory macrophages of the M1 phenotype and enhances atherosclerosis.
Journal: Journal of cellular physiology
Published: August 19, 2012
Thioredoxin-1 promotes anti-inflammatory macrophages of the M2 phenotype and antagonizes atherosclerosis.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: April 21, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026